Pharma

Review of scheduled, unscheduled, and foreign GMP inspections of pharmaceutical production facilities (June 2026)

This analytical review is based on official data obtained from the Register of GMP inspection results published by the...

Experts continue to discuss possible changes to the regulations governing veterinary drugs in the EAEU

On June 23, a working meeting of experts was held at the Russian Union of Industrialists and Entrepreneurs (RSPP)...

GMP Registry Update: 7 New Certificates and 2 Refusals in Late April 2026

The Ministry of Industry and Trade of the Russian Federation has added new data to the "Information on Issued,...

Dmitry Kudlay: Russian Technologies Break Into the Global Stage But Stall in Public Procurement

Russian pharmaceutical science has reached a level where innovative drugs generate genuine interest in the West, yet advanced developments...

PSK Pharma Challenges Pfizer’s Rheumatoid Arthritis Drug Patent in Court

Russian pharmaceutical company PSK Pharma has filed a lawsuit against the American corporation Pfizer in the Intellectual Property Court...

ST-1 Certificate Outweighs Active Substance: Court Forbids State Buyers from Reevaluating Drug Origin

The Arbitration Court of Moscow has issued a precedent-setting ruling protecting Russian pharmaceutical manufacturers from excessive requirements in public...
spot_imgspot_img

TSU Scientists Synthesize Pharmaceutical Raw Materials from Capron Production By-products

As part of the development of waste-free production and green chemistry principles, researchers at Togliatti State University (TSU) have...

Minpromtorg to Compensate Pharma Companies for Clinical Trial Costs Starting in 2027

The Ministry of Industry and Trade of the Russian Federation has announced the launch of a new support measure...

Big Pharma 2025: Biggest Winners, New Leaders, and Major Drops in the Top 20 Rankings

The worldwide pharmaceutical industry has summarized its financial results for 2025. As reported by FiercePharma, despite patent cliffs, pricing...

Real-World Clinical Trial of Josamycin-Based Antibiotic Launched in Russia

The Russian biopharmaceutical company Promomed has announced the start of a medical study for its new antibiotic Vilpramycin SAR®...

State Duma Finally Approves Law on Mobile Pharmacies

The State Duma of the Russian Federation has adopted amendments to the Law "On the Circulation of Medicines" in...

Russia Simplifies Market Entry for New Veterinary Vaccines: Notification Procedure Established

The Government of the Russian Federation has decided to significantly reduce administrative barriers for the market launch of new...